Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency. BioDrugs vol
Stick to the dry, middle section
What You Should Know: A new study from Mayo Clinic, released this past weekend, signals a significant advancement in understanding and potentially mitigating the challenging side effects associated with popular GLP-1 agonist medications like Wegovy and Zepbound
In these cases, doctors monitor patients closely to make sure the medication is working well and is safe to use
For liver function estimation, a logistic regression model was built on 709 and evaluated on 300 cirrhotic patients undergoing hepatocellular carcinoma surveillance
However, discontinuing these medicines can lead to significant metabolic changes, including deterioration in blood glucose control and weight regain